News Zeria Pharmaceutical Co., Ltd.

Equities

4559

JP3428850006

Delayed Japan Exchange Other stock markets 11:30:00 28/06/2024 am IST			5-day change	1st Jan Change
2,113 ^JPY	+0.14%		+2.67%	+4.76%

09/05	Zeria Pharmaceutical Co., Ltd. Provides Consolidated Earnings Guidance for the First Six Months and Full Year Ending March 31, 2025	CI
23/04	Borsch Med Pte. Ltd. Introduces Chondroitin Supplements of Zeria Pharmaceutical Co. Ltd to Singapore for Healthy Joints	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Zeria Pharmaceutical's Attributable Profit Soars 24.8% in Fiscal 2024	03/06	MT
Zeria Pharmaceutical Co., Ltd. Announces Year End Dividend for the Full Year Ending March 31, 2024, Payable on June 28, 2024	09/05	CI
Zeria Pharmaceutical Co., Ltd. Provides Consolidated Earnings Guidance for the First Six Months and Full Year Ending March 31, 2025	09/05	CI
Zeria Pharmaceutical Co., Ltd. Provides Second Quarter and Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2025	09/05	CI
Borsch Med Pte. Ltd. Introduces Chondroitin Supplements of Zeria Pharmaceutical Co. Ltd to Singapore for Healthy Joints	23/04	CI
Final dividend	28/03	FA
Zeria Pharmaceutical's Profit Up 41% in Fiscal Q1-Q3	16/02	MT
Japanese Shares End Firmer on Friday on BoJ Policy Outlook	17/11	MT
Zeria Pharmaceutical Books Higher Fiscal H1 Attributable Profit on Loss Provision Reversal	17/11	MT
Zeria Pharmaceutical Co., Ltd. Announces Dividend for the Second Quarter of Fiscal Year Ending March 31, 2024, Payable on December 1, 2023	16/11	CI
Zeria Pharmaceutical Co., Ltd. Provides Dividend Guidance for the Year Ending March 31, 2024	16/11	CI
Ex-dividend day for interim dividend	28/23/28	FA
Zeria Pharmaceutical’s Attributable Profit Up 12.1% in Fiscal Q1 on Absence of Forex Losses	23/23/23	MT
Zeria Pharmaceutical Co., Ltd. Provides Dividend Forecast for the Fiscal Year Ending March 31, 2024	22/23/22	CI
Zeria Pharmaceutical Co., Ltd. Provides Consolidated Financial Forecast for the Six Months of 2024 and the Fiscal Year Ending March 31, 2024	22/23/22	CI
Zeria Pharmaceutical Co., Ltd. Provides Dividend Forecast for the Second Quarter of 2024	22/23/22	CI
Zeria Pharmaceutical : 69th Business Report (From April 1, 2022 to March 31, 2023.)	25/23/25	PU
Zeria Pharmaceutical : Notice of the 69th Ordinary Stockholders' General Assembly	26/23/26	PU
Tranche Update on Zeria Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 11, 2022.	16/23/16	CI
Zeria Pharmaceutical Co., Ltd.'s Equity Buyback announced on May 11, 2022, has closed with 263,900 shares, representing 0.6% for ¥545.29 million.	12/23/12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Zeria Pharmaceutical Co., Ltd.

Equities

4559

JP3428850006

Summary

Filters